GW&K Investment Management LLC Increases Stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

GW&K Investment Management LLC increased its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 50.8% in the first quarter, Holdings Channel.com reports. The firm owned 2,603,931 shares of the biotechnology company’s stock after acquiring an additional 876,844 shares during the period. GW&K Investment Management LLC’s holdings in BioCryst Pharmaceuticals were worth $21,717,000 at […]

Related Keywords

United States ,America ,Machelle Sanders ,Biocryst Pharmaceuticals Company Profile ,Biocryst Pharmaceuticals ,Biocryst Pharmaceuticals Stock Performance ,Nasdaq ,News Ratings For Biocryst Pharmaceuticals Daily ,Millennium Management ,Quarter For Biocryst Pharmaceuticals ,Biocryst Pharmaceuticals Inc ,Gwk Investment Management ,Needham Company ,Insider Transactions At Biocryst Pharmaceuticals ,Vanguard Group Inc ,Jefferies Financial Group ,Holdings Channel ,Free Report ,Street Corp ,Financial Group ,Cryst Pharmaceuticals ,Get Free Report ,Director Machelle Sanders ,Visit Holdingschannel ,Biocryst Pharmaceuticals Daily ,Nasdaq Bcrx ,Bcrx ,Medical ,09058v10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,